Sign In

Shahid Azim

CEO and Managing Partner Stealth AI Venture Studio I instructor Media Lab MIT II Serial Health Tech Entrepreneur

Shahid Azim is a dedicated professional deeply involved in COVID-related initiatives at CICH. With a passion for creating impactful products, Shahid Azim is the CEO and Co-founder of various ventures like REACTNeuro, Nanogenecs, Quanttus, Lantos, and Braintree.

Shahid Azim's academic background is impressive, having completed an MBA with a focus on Entrepreneurship & Innovation as a Sloan Fellow at the prestigious Massachusetts Institute of Technology's Sloan School of Management. Additionally, Shahid Azim pursued post-graduate studies in Business Administration at Harvard University and holds a BBA in Finance with specializations in Finance & Entrepreneurship from Seattle University.

Throughout his career, Shahid Azim has held key positions in prominent organizations, including serving as the CEO & Managing Partner at Studio 2139. He has also contributed to academia as an Instructor for AI for Impact at MIT Media Lab and as a Mentor/Advisor for the AI for Impact Venture Studio Class at Massachusetts Institute of Technology. Furthermore, Shahid Azim has played pivotal roles in various healthcare and technology companies, such as CIC Health, REACT Neuro, Nanogenecs Diagnostics, Quanttus, and Lantos Technologies, where he held positions ranging from Founder to CEO to Board Member.

Shahid Azim
Add to my network

Location

Cambridge, Massachusetts, United States